• Malignant neoplasm, renal pelvis (kidney)
  • Acetaminophen, Urine
  • Chlamydia trachomatis NAAT, Swab
  • Platelet Antibodies, Serum
  • Creatine Kinase (CK)
  • Celiac Disease Antibody Panel
  • Secondary hypopituitarism
  • Vitamin A
  • Brompheniramine
  • Glucose Tolerance Test, 1 Hour Post-50g Oral Ingestion
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

LOINC
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...